Get the Stockscreener App
419.26
2.18%
-9.36
After Hours:
419.26
Idexx Laboratories Inc stock is traded at $419.26, with a volume of 788.19K.
It is down -2.18% in the last 24 hours and down -1.83% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$428.62
Open:
$429.3
24h Volume:
788.19K
Relative Volume:
1.26
Market Cap:
$34.33B
Revenue:
$3.84B
Net Income/Loss:
$866.24M
P/E Ratio:
40.43
EPS:
10.37
Net Cash Flow:
$792.60M
1W Performance:
+0.29%
1M Performance:
-1.83%
6M Performance:
-15.55%
1Y Performance:
-18.67%
1-Day Range:
$418.66
$432.95
1-Week Range:
$412.68
$432.95
52-Week Range:
$398.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Short Interest in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Increases By 7.1% - MarketBeat
Seilern Investment Management Ltd Takes $113.10 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing? - Yahoo Finance
Sax Wealth Advisors LLC Purchases 617 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
RDA Financial Network Grows Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Carderock Capital Management Inc. Has $5.69 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Avanza Fonder AB Invests $2.69 Million in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Gateway Investment Advisers LLC Purchases 1,274 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Oak Thistle LLC Makes New $426,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories Sets Q4 and Full Year 2024 Earnings Release Date for February 3 - StockTitan
Claro Advisors LLC Cuts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market - MarketWatch
IDEXX Stock Suffers Due to Macroeconomic Issues and FX Woes - Yahoo Finance
Assenagon Asset Management S.A. Buys 316,048 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
CHICAGO TRUST Co NA Decreases Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Declining Stock and Solid Fundamentals: Is The Market Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - Yahoo Finance
International Assets Investment Management LLC Sells 527,447 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories' Quarterly Earnings Preview: What You Need to Know - Nasdaq
IDEXX Laboratories' Quarterly Earnings Preview: What You Need To Know - Barchart
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Westwind Capital Raises Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Bath Savings Trust Co Sells 3,308 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Insight Wealth Strategies LLC Has $4.17 Million Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by JPMorgan Chase & Co. - MarketBeat
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo Finance
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly - Simply Wall St
IDEXX Laboratories Inc. stock rises Tuesday, still underperforms market - MarketWatch
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
IDEXX Laboratories Inc. stock rises Monday, still underperforms market - MarketWatch
Is IDEXX Laboratories Stock Underperforming the S&P 500? - MSN
IDEXX Laboratories Inc. stock rises Friday, still underperforms market - MarketWatch
Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback? - Insider Monkey
IDEXX Laboratories (NASDAQ:IDXX) Issues FY 2024 Earnings Guidance - MarketBeat
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX - The Manila Times
IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 9.3% CAGR delivered to shareholders - Yahoo Finance
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories' SWOT analysis: veterinary diagnostics leader faces market headwinds - Investing.com India
Wilmington Savings Fund Society FSB Has $999,000 Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Franklin Resources Inc. Boosts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):